학술논문

PHASE 1 STUDY OF SEA-TGT, A HUMAN, NONFUCOSYLATED ANTI-TIGIT MONOCLONAL ANTIBODY WITH ENHANCED IMMUNE-EFFECTOR FUNCTION, IN PATIENTS WITH ADVANCED MALIGNANCIES (SGNTGT-001, TRIAL IN PROGRESS)
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 2021, 9 pA503-pA503, 1p. Supplement: 2
Subject
Language
English
ISSN
20511426